NCT00471562View on ClinicalTrials.gov

Angiotensin-(1-7) in Treating Patients With Metastatic or Unresectable Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
BIOLOGICAL

therapeutic angiotensin-(1-7)

sequentially increasing doses 50-1000 mcg/kg

Trial Locations (1)

27157-1096

Wake Forest University Comprehensive Cancer Center, Winston-Salem

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Wake Forest University Health Sciences

OTHER

NCT00471562 - Angiotensin-(1-7) in Treating Patients With Metastatic or Unresectable Solid Tumors | Biotech Hunter | Biotech Hunter